Aldevron CRISPR/Cas9 Gene Editing Tools

Aldevron CRISPR/Cas9 Gene Editing Tools

Contract Manufacturing

Information

From research through clinical development, Aldevron provides a one-vendor strategy for preclinical through GMP gene editing nucleases. Using Cas9 in protein form provides many benefits, including reduced off-target effects, immediate intracellular activity and controlled dosage capabilities. Aldevron gene editing nucleases are available as catalog products in standard formulations and can be custom manufactured to meet your exact needs.
AldevronLatest News: Aldevron Ranked Number 287 Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500™  Founded in 1998, Aldevron serves the biotechnology industry with custom production of nucleic acids, proteins, and antibodies. Thousands of clients worldwide rely on Aldevron-produced plasmid DNA, RNA, gene editing enzymes and more for biological research projects from discovery to clinical trials and commercial applications. These efforts help accelerate development of treatments for diseases such as cancer, infectious disease, pediatric disorders and rare diseases. Aldevron specializes in cGMP manufacturing and is known for inventing the GMP-Source® quality system. Our mission is to be a partner in the development of medicines that improve patients’ lives while serving clients, employees, and the community, while constantly looking for new and better ways to give researchers the products and services they need. Aldevron operates the largest cGMP plasmid DNA manufacturing facility in the world, located in Fargo, North Dakota, which serves as company headquarters, with additional production facilities in Madison, Wisconsin.  What can we do for you? Learn more about our products and services on our website  Watch our continuing growth as our campus expands!  Want to join the fastest growing biologics manufacturer in the region? Aldevron is hiring! 

Join the event!